China’s biotech market is staging a comeback that US biotech can only wish fornews2025-04-23T14:00:55+00:00April 23rd, 2025|Endpoints News|
Drugmakers stockpile inventory in the US, seeking to get ahead of Trump tariffsnews2025-04-22T14:00:06+00:00April 22nd, 2025|Endpoints News|
China biotech startup HuidaGene uses CRISPR in brain for rare ailmentnews2025-04-21T15:00:57+00:00April 21st, 2025|Endpoints News|
China-based VelaVigo inks its second US biotech dealnews2025-04-17T19:00:02+00:00April 17th, 2025|Endpoints News|
Trump’s Tariff Threat for Drug imports Poses Big Political Risksnews2025-04-15T14:33:12+00:00April 15th, 2025|The New York Times|
Trump Moves to Put New Tariffs on Computer Chips and Drugsnews2025-04-14T23:03:07+00:00April 14th, 2025|The New York Times|
BioNTech-backed ADC maker DualityBio plans Hong Kong IPOnews2025-04-14T19:23:17+00:00April 14th, 2025|Endpoints News|
US commission calls for $15B biotech investment to blunt Chinanews2025-04-08T04:01:22+00:00April 8th, 2025|Endpoints News|
ADC startup DualityBio seeks Hong Kong IPO amid precarious marketnews2025-04-07T11:35:57+00:00April 7th, 2025|Endpoints News|
Boston Faces Identity Crisis Amid Trump’s Cuts to University and Research Fundingnews2025-04-06T09:01:05+00:00April 6th, 2025|The New York Times|
